Sign in: Staff/Students
Proteins in the blood called histones, which are released from damaged tissues during sepsis, can cause life-threatening heart failure, according to new research from the University of Liverpool.
The finding that histones affect the heart’s ability to pump, points the way toward a new treatment against the deadly effects of a septic infection.
Sepsis is a life-threatening condition caused by the body’s response to an infection. It leads to more than 100,000 people being admitted to hospital in the UK each year. Over a third (around 37,000) of people admitted with sepsis die, more than from any single type of cancer.
While previous research showed a link between elevated levels of histones in the blood and heart damage in patients with sepsis, it was not clear how histones were harmful to the heart. Now the Liverpool team, led by Professor Cheng-Hock Toh and Dr Guozheng Wang from the University’s Institute of Infection and Global Health, have found how histones affect the heart in mice.
Histones are usually found in the cell’s nucleus and act like spools around which the DNA winds so it can be tightly packaged together. Once large numbers of cells die, the histones are released into the blood causing harmful effects.
The researchers discovered that histones affect the left and right side of the heart differently, dependent on the levels of histone in the blood. Higher doses of histone were found to be more damaging but the left side of the heart was affected by even moderate doses.
Dr Guozheng Wang, said: “We learnt that histones have a damaging effect on the levels of calcium in heart muscle cells, which affects heart rhythm and the cells ability to beat properly.
“Importantly we also found that an ‘anti-histone treatment’ cancelled out the toxic effects of the histones on heart cells suggesting we could develop a drug to successfully treat some of the damaging effects of sepsis on the heart.
“Our team is now looking at what levels of histone cause damage on the heart during sepsis before we begin looking further at testing new treatments, which could ultimately help save the lives of thousands of people.”
Potential new treatments
Professor Jeremy Pearson, Associate Medical Director at the British Heart Foundation, which helped fund the research, said: “Treatments for the effects of sepsis on the heart and blood vessels are urgently needed and they will only come through research such as this.
“Although at an early stage, these findings point to a promising way to target and treat the heart damage associated with sepsis. These results, along with the team’s earlier work, also offer the possibility of developing a test, measuring histone levels, which could be used to identify the patients suffering from sepsis who are at greatest risk of heart problems.”
‘Circulating Histone Concentrations Differentially Affect the Predominance of Left or Right Ventricular Dysfunction in Critical Illness‘ is published in the journal Critical Care Medicine.
You must be logged in to post a comment.
All recent news
University launches UK first Research Technical Professional Career Pathway
New digital tools use climate data to tackle infectious disease outbreaks
World Cancer Day: A year in research
Eurovision needs you – volunteering opportunities available
Don’t miss the Refreshers Fair!
Today is #WorldCancerDay and an opportunity for us to reflect on a busy year for cancer research for #TeamLivUni scientists, who continue to work on prevention, screening, diagnostics & therapeutics for the benefit of cancer patients.
Read more here: https://news.liverpool.ac.uk/2023/02/03/world-cancer-day-a-year-in-research/
In a UK first, we've launched a new Research Technical Professional Career Pathway. Technical & research support staff are essential to UK research & innovation, and this scheme aims to improve the career pathways of colleagues in these roles.
A new digital tool will use climate data to help better predict and prepare for infectious disease outbreaks in the Horn of Africa.
Funded by @wellcometrust, the project is led by @LivUni_IVES with partners from Italy, Kenya, Ethiopia, Uganda & Somalia.